NCT06625762

Brief Summary

While current research suggests that inflammation of adipose tissue in obesity is linked to accelerated aging, it has yet to be determined in humans how this could enhance preventative and personalized medicine for obese individuals. The NBC study aims to investigate :

  1. 1.Whether bariatric surgery is associated with changes in biological age
  2. 2.If bariatric surgery alters adipocyte dysfunction, the microbiota and biological rhythms
  3. 3.Whether changes in adipocyte dysfunction, microbiota and biological rhythms are linked to changes in biological age.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
300

participants targeted

Target at P75+ for not_applicable obesity

Timeline
22mo left

Started Mar 2025

Typical duration for not_applicable obesity

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress41%
Mar 2025Mar 2028

First Submitted

Initial submission to the registry

September 3, 2024

Completed
1 month until next milestone

First Posted

Study publicly available on registry

October 3, 2024

Completed
5 months until next milestone

Study Start

First participant enrolled

March 1, 2025

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2027

Expected
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2028

Last Updated

December 2, 2024

Status Verified

June 1, 2024

Enrollment Period

2 years

First QC Date

September 3, 2024

Last Update Submit

November 28, 2024

Conditions

Keywords

ObesityBariatric surgeryBiological agingAdipocyte dysfunctionBiological rhythms

Outcome Measures

Primary Outcomes (1)

  • Observe how biological age evolves between pre-bariatric surgery and 1 year after bariatric surgery

    Biological age will be estimated by measuring phenotypic age. The phenotypic age will be determined from the following variable: albumin, creatinine, fasting glucose, CRP, lymphocyte count, red cell size, alkaline phosphates, leukocyte count.

    1 year

Study Arms (1)

observation of the change in biological age after bariatric surgery

OTHER

Patients over 18 years of age suffering from obesity and requiring bariatric surgery. Evolution of biological age 1 year after surgery, defined by the difference between age biological at TPO and TAC 1 year, estimated by measuring the phenotypic age, itself determined from the following eight variables: albumin; creatinine; fasting blood sugar; CRP ; lymphocyte count; mean corpuscular volume of red blood cells; Anisocytosis index of red blood cells; alkaline phosphatases; leukocyte rate.

Other: Nantes bariatric surgery cohort

Interventions

The participants will be individuals living with obesity undergoing bariatric surgery

observation of the change in biological age after bariatric surgery

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • male or female, adult over 18 years of age
  • BMI ≥ 35 kg/m2 with complication(s) or ≥ 40 kg/m2 with or without complication (the list of eligible complications is referenced in HAS 2024 recommendations). In the event of a change in access to bariatric surgery, this threshold could be revised without any substantial change to the protocol.
  • having consented to their participation in the cohort
  • participant affiliated to or benefiting from a social security scheme

You may not qualify if:

  • Persons protected by law (guardianship or trusteeship) or deprived of their freedom,
  • Pregnant women (contraindication to CB) or nursing mothers.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Nantes University Hospital

Nantes, Loire-Atlantique, 44093, France

Location

MeSH Terms

Conditions

Obesity

Condition Hierarchy (Ancestors)

OverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • David JACOBI, PU-PH

    Nantes University Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
PREVENTION
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 3, 2024

First Posted

October 3, 2024

Study Start

March 1, 2025

Primary Completion (Estimated)

March 1, 2027

Study Completion (Estimated)

March 1, 2028

Last Updated

December 2, 2024

Record last verified: 2024-06

Locations